Psoriasis and dyslipidemia: A population-based study analyzing the National Health and Nutrition Examination Survey (NHANES)

Journal of the European Academy of Dermatology and Venereology

Volumn 28, Issue 8, 2014, Pages 1109-1112

  Ma, C ^a   Schupp, C W ^a   Armstrong, E J ^b   Armstrong, A W ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; COMPLICATION; CROSS-SECTIONAL STUDY; DYSLIPIDEMIA; FEMALE; HEALTH SURVEY; HUMAN; MALE; MIDDLE AGED; NUTRITION; PSORIASIS;

ADULT; CROSS-SECTIONAL STUDIES; DYSLIPIDEMIAS; FEMALE; HUMANS; MALE; MIDDLE AGED; NUTRITION SURVEYS; POPULATION SURVEILLANCE; PSORIASIS;

EID: 84905864312     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/jdv.12232     Document Type: Article

References (20)

1. Kurd SK, Gelfand JM,. The prevalence of previously diagnosed and undiagnosed psoriasis in US adults: results from NHANES 2003-2004. J Am Acad Dermatol 2009; 60: 218-224.
2. Ahlehoff O, Gislason GH, Jorgensen CH, et al,. Psoriasis and risk of atrial fibrillation and ischaemic stroke: a Danish Nationwide Cohort Study. Eur Heart J 2011; 33: 2054-2064.
3. Gelfand JM, Neimann AL, Shin DB, et al,. Risk of myocardial infarction in patients with psoriasis. JAMA 2006; 296: 1735-1741. (Pubitemid 44547793)
4. Armstrong EJ, Harskamp CT, Armstrong AW,. Psoriasis and major adverse cardiovascular events: a systematic review and meta-analysis of observational studies. J Am Heart Assoc 2013; 2: e000062.
5. Prey S, Paul C, Bronsard V, et al,. Cardiovascular risk factors in patients with plaque psoriasis: a systematic review of epidemiological studies. J Eur Acad Dermatol Venereol 2010; 24 (Suppl. 2): 23-30.
6. Armstrong AW, Voyles SV, Armstrong EJ, et al,. Angiogenesis and oxidative stress: common mechanisms linking psoriasis with atherosclerosis. J Dermatol Sci 2011; 63: 1-9.
7. Miller M, Seidler A, Moalemi A, et al,. Normal triglyceride levels and coronary artery disease events: the Baltimore Coronary Observational Long-Term Study. J Am Coll Cardiol 1998; 31: 1252-1257. (Pubitemid 128713120)
8. Program NCE. Third Report of the Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. National Institutes of Health, Bethesda, MD, 2002.
9. Armstrong AW, Voyles SV, Armstrong EJ, et al,. A tale of two plaques: convergent mechanisms of T-cell-mediated inflammation in psoriasis and atherosclerosis. Exp Dermatol 2011; 20: 544-549.
10. Feingold KR, Grunfeld C,. Role of cytokines in inducing hyperlipidemia. Diabetes 1992; 41 (Suppl. 2): 97-101.
11. Greenberg AS, Nordan RP, McIntosh J, et al,. Interleukin 6 reduces lipoprotein lipase activity in adipose tissue of mice in vivo and in 3T3-L1 adipocytes: a possible role for interleukin 6 in cancer cachexia. Cancer Res 1992; 52: 4113-4116.
12. Arican O, Aral M, Sasmaz S, et al,. Serum levels of TNF-alpha, IFN-gamma, IL-6, IL-8, IL-12, IL-17, and IL-18 in patients with active psoriasis and correlation with disease severity. Mediators Inflamm 2005; 2005: 273-279. (Pubitemid 41577417)
13. Ortonne JP,. Recent developments in the understanding of the pathogenesis of psoriasis. Br J Dermatol 1999; 140 (Suppl. 54): 1-7.
14. Takahashi H, Tsuji H, Hashimoto Y, et al,. Serum cytokines and growth factor levels in Japanese patients with psoriasis. Clin Exp Dermatol 2010; 35: 645-649.
15. Memon RA, Grunfeld C, Moser AH, et al,. Tumor necrosis factor mediates the effects of endotoxin on cholesterol and triglyceride metabolism in mice. Endocrinology 1993; 132: 2246-2253. (Pubitemid 23133278)
16. Feingold KR, Marshall M, Gulli R, et al,. Effect of endotoxin and cytokines on lipoprotein lipase activity in mice. Arterioscler Thromb 1994; 14: 1866-1872.
17. Love TJ, Qureshi AA, Karlson EW, et al,. Prevalence of the metabolic syndrome in psoriasis: results from the National Health and Nutrition Examination Survey, 2003-2006. Arch Dermatol 2011; 147: 419-424.
18. Chen DY, Chih HM, Lan JL, et al,. Blood lipid profiles and peripheral blood mononuclear cell cholesterol metabolism gene expression in patients with and without methotrexate treatment. BMC Med 2011; 9: 4.
19. Ghosh UC, Roy A, Sen K, et al,. Dyslipidaemia in rheumatoid arthritis in a tertiary care centre in Eastern India-a non-randomised trial. J Indian Med Assoc 2009; 107: 427-430.
20. Pereira MJ, Palming J, Rizell M, et al,. The immunosuppressive agents rapamycin, cyclosporin A and tacrolimus increase lipolysis, inhibit lipid storage and alter expression of genes involved in lipid metabolism in human adipocytes. Mol Cell Endocrinol 2012; 365: 260-269.